AlphaStreet

AbbVie Q3 2018 Earnings Infographics
AlphaStreet
During the quarter, AbbVie received FDA approval of Humira for the treatment of non-infectious intermediate, posterior, and panuveitis in patients down to 2 years of age and for the treatment of hidradenitis suppurativa in adolescent patients 12 years
Trump signs STOP Act aimed at opioid crisisSeeking Alpha
Abbvie Inc. – ABBV – Stock Price Today – ZacksZacks
SEC FORM 4 – SEC.govSEC.gov

all 238 news articles »

X